Friday, April 23, 2021

Tag: Dalton Dietrich

Transplantation Safety Trial Using Schwann Cells Completed Successfully

The Miami Project, at the University of Miami Miller School of Medicine, today announced the publication of its first Food and Drug Administration (FDA) approved Phase I clinical trial involving Schwann cells used to...

Promising new therapy could ‘cure’ paralyzed patients

Dr. W. Dalton Dietrich, scientific director of the Miami Project to Cure Paralysis, was in Washington this week seeking U.S. Food and Drug Administration approval to start a clinical safety trial of a remarkable...